Patent · US Active

Target populations of oligodendrocyte precursor cells and methods of making and using same

US10400214B2 · kind B2 · utility

0Cited by

53References

13Claims

0Family size

Assignee

BOCO SILICON VALLEY, INC. · US

Inventors

Alexandra Capela · Mountain View, US
Nobuko Uchida · Palo Alto, US

Key dates

Filing date	Nov 17, 2017
Grant date	Sep 3, 2019
Priority date	—
Expiry date	Nov 17, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2501/135
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application provides for enriched target populations oligodendrocyte precursor cells (OPCs) that can differentiate into oligodendrocytes. The target OPCs may be expanded and optionally subjected to conditions to induce their differentiation into oligodendrocytes. The target OPCs and their progeny are useful for the treatment of disease associated with demyelination of central nervous system axons.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.